Uruguay Establishes Regulatory Framework for Cannabis Cosmetics, Restricts Medical Claims

Uruguay has implemented specific regulatory requirements for cannabis-derived cosmetics, including CBD and CBG as permitted ingredients, with mandatory registration and labeling standards. The new framework prohibits manufacturers from making medical claims or therapeutic promises on cannabis cosmetic products. This regulatory approach distinguishes between cosmetic and pharmaceutical applications, ensuring consumer protection while establishing clear compliance guidelines. The rules represent a balanced policy that acknowledges cannabis ingredients in skincare while preventing misleading health claims that lack sufficient clinical evidence.